Antibody Production Market, End Users (Research Institutes, Diagnostic Laboratories, and Biotechnology, and Pharmaceutical Companies), Process (Filtration, Upstream Processing, and Downstream Processing), Filtration Segment (Filtration Consumables and Accessories, and Filtration Systems), Upstream Segment (Consumables, and Bioreactors), Consumables(Buffers & Reagents, and Media), Bioreactors(Single-Use Bioreactors and Large-Scale Bioreactors) Global Industry Perspective, Comprehensive Analysis and Forecast, 2020 – 2026

Description

According to the report published by Zion Market Research, global demand for the Antibody Production market was valued at approximately USD 10.86 Billion in 2019 and is expected to generate revenue of around USD 24.00 Billion by end of 2026, growing at a CAGR of around 12.01% between 2020 and 2026.

Global Antibody Production Market: Overview

The immune system produces antibodies secreted in the blood, which are protein molecules produced in response to the antigens, foreign particles such as viruses, fungi, and bacteria. The antibodies function by neutralizing or inhibiting the antigen activity. The production of an antibody is dependent on the humoral response of the immune system to the introduction of foreign particles into the body. Polyclonal antibodies and monoclonal antibodies are the basic types of antibodies produced by the immune system. Polyclonal antibodies are produced from many dissimilar immune cells whereas monoclonal antibodies are produced by similar immune cells which are duplicates of a distinctive progenitor cell. The antibody production market consists of products essential for various steps of processing of antibodies, such as downstream processing, filtration, and upstream processing.

Global Antibody Production Market: Growth Factors

The major factors contributing to the growth of the antibody production market are the increasing need for protein curatives and the rising widespread presence of infectious disease. The other factors propelling the growth of the market are the patent cessation of successful monoclonal antibodies, raised R&D disbursement of biotechnology and pharmaceutical companies, rising acceptance of targeted immunotherapy, and therapeutic antibodies by governing authorities.

Global Antibody Production Market: Segmentation

The antibody production market may be classified based on end-users and process. The end-users segment of the global market can be further divided into research institutes, diagnostic laboratories, and biotechnology and pharmaceutical companies. The biotechnology and pharmaceutical companies segment is anticipated to grow the most owing to the huge digit of drug development processes to meet the decreased industry timelines, attracting the companies to invest in the developmental and research activities. The process segment of the market may be divided into filtration, upstream processing, and downstream processing. The filtration segment of the market can be further categorized as filtration consumables and accessories and filtration systems. The upstream segment of the global antibody production market can be diversified into consumables and bioreactors. The consumables segment is sub-segmented as buffers & reagents and the media and bioreactors segment is sub-segmented as single-use bioreactors and large-scale bioreactors. The downstream segment can be categorized into chromatography resins and chromatography systems. The need for advanced and sensitive tools is expected to boost the growth of the downstream processing segment.

The antibody production market can also be segmented on the basis of application and type. The application segment of the market is further classified into cardiology, rheumatology, hematology/oncology, gastroenterology, transplantation, and infection. The type segment of the antibody production market can be categorized into polyclonal antibodies and monoclonal antibodies. The monoclonal antibody segment is further sub-segmented into humanized, murine, and chimeric.

 Region-wise, the global market is segregated into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa.

Global Antibody Production Market: Regional Analysis

North America is anticipated to be the rapidly growing region in the antibody production market due to government expenditure, increasing cancer incidence, and the requirement for quality cancer therapy. The Asia-Pacific region is also expected to boost in the market owing to the rising private sector and government expenditure, increasing infrastructural advancements, and government support.

Global Antibody Production Market: Competitive Players

The major players in the antibody production market are Sigma-Aldrich Corporation, GE Healthcare, Thermo Fisher Scientific, Inc., INTEGRA Biosciences AG, Cellab GmbH, and Eppendorf AG. The other prominent players in the market include Sartorius AG, Pall Corporation, Merck KGaA, and FiberCell Systems Inc.

Antibody Production Market: Regional Segment Analysis

• North America
  • The U.S.
  • Canada
• Europe
  • France
  • The UK
  • Spain
  • Germany
  • Italy
  • Rest of Europe
• Asia Pacific
  • China
  • Japan
  • India
  • South Korea
  • Southeast Asia
  • Rest of Asia Pacific
• Latin America
  • Brazil
  • Mexico
  • Rest of Latin America
• Middle East & Africa
  • GCC
  • South Africa
  • Rest of Middle East & Africa

Table Of Content

• Chapter 1.Preface
  • 1.1.Report Description
  • 1.2.Report Scope
• Chapter 2.Research Methodulogy
  • 2.1.Research Methodulogy
  • 2.2.Secondary Research
  • 2.3.Primary Research
  • 2.4.Models
    • 2.4.1.Company Share Analysis Model
    • 2.4.2.Revenue Based Modeling
  • 2.5.Research Limitations
• Chapter 3.Executive Summary
  • 3.1.Global Antibody Production Market, 2016 – 2026 (USD Million)
  • 3.2.Global Antibody Production Market: Snapshot
• Chapter 4.Antibody Production Market – Industry Analysis
  • 4.1.Introduction
  • 4.2.Market Drivers
    • 4.2.1.Driving Factor 1 Analysis
    • 4.2.2.Driving Factor 2 Analysis:
  • 4.3.Market Restraints
    • 4.3.1.Restraining Factor Analysis
  • 4.4.Market Opportunities
    • 4.4.1.Market Opportunity & Use-case Anaysis
    • 4.4.2.Use – Cases for Antibody Production
  • 4.5.Porter’s Five Forces Analysis
  • 4.6.COVID 19 Impact Analysis
    • 4.6.1.1.Impact on Product Development and Technulogy Adoption
    • 4.6.1.2.Gap Analysis

• Chapter 5.Investment Proposition Analysis
  • 5.1.Global Antibody Production Market Attractiveness, By End User
  • 5.2.Global Antibody Production Market Attractiveness, By Process
  • 5.3.Global Antibody Production Market Attractiveness, By Filtration Segment
  • 5.4.Global Antibody Production Market Attractiveness, By Upstream Segment
  • 5.5.Global Antibody Production Market Attractiveness, By Consumables
  • 5.6.Global Antibody Production Market Attractiveness, By Bioreactors
  • 5.7.Global Antibody Production Market Attractiveness, By Region
• Chapter 6.Competitive Landscape
  • 6.1.Company Market Share Analysis - 2019
    • 6.1.1.Global Antibody Production Market: Company Market Share, 2019
  • 6.2.Strategic Developments
• Chapter 7.End User-Segmentation Analysis
  • 7.1.Global Antibody Production Market Overview: by End User
    • 7.1.1.Global Antibody Production Market Revenue Share, by End User, 2019 & 2026
  • 7.2.Global Antibody Production Market Analysis/Overview – By End User
    • 7.2.1.Research Institutes – Overview/Analysis
    • 7.2.2.Diagnostic Laboratories – Overview/Analysis
    • 7.2.3.Biotechnulogy – Overview/Analysis
    • 7.2.4.Pharmaceutical Companies – Overview/Analysis
  • 7.3.Research Institutes
    • 7.3.1.Global Antibody Production Market for Research Institutes, Revenue (USD Million) 2016 - 2026
  • 7.4.Diagnostic Laboratories
    • 7.4.1.Global Antibody Production Market for Diagnostic Laboratories, Revenue (USD Million) 2016 - 2026
  • 7.5.Biotechnulogy
    • 7.5.1.Global Antibody Production Market for Biotechnulogy, Revenue (USD Million) 2016 - 2026
  • 7.6.Pharmaceutical Companies
    • 7.6.1.Global Antibody Production Market for Pharmaceutical Companies, Revenue (USD Million) 2016 - 2026
• Chapter 8.Process Segmentation Analysis
  • 8.1.Global Antibody Production Market Overview: by Process
    • 8.1.1.Global Antibody Production Market Revenue Share, by Process, 2019 & 2026
  • 8.2.Global Antibody Production Market Analysis/Overview – By Process
    • 8.2.1.Filtration – Overview/Analysis
    • 8.2.2.Upstream Processing – Overview/Analysis
    • 8.2.3.Downstream Processing – Overview/Analysis
  • 8.3.Filtration
    • 8.3.1.Global Antibody Production Market for Filtration, Revenue (USD Million) 2016 - 2026
  • 8.4.Upstream Processing
    • 8.4.1.Global Antibody Production Market for Upstream Processing, Revenue (USD Million) 2016 - 2026
  • 8.5.Downstream Processing
    • 8.5.1.Global Antibody Production Market for Downstream Processing, Revenue (USD Million) 2016 - 2026
• Chapter 9.Filtration Segmentation Analysis
  • 9.1.Global Antibody Production Market Overview: by Filtration Segment
    • 9.1.1.Global Antibody Production Market Revenue Share, by Filtration Segment, 2019 & 2026
  • 9.2.Global Antibody Production Market Analysis/Overview – By Filtration Segment
    • 9.2.1.Filtration Consumables and Accessories – Overview/Analysis
    • 9.2.2.Filtration Systems – Overview/Analysis
  • 9.3.Filtration Consumables and Accessories
    • 9.3.1.Global Antibody Production Market for Filtration Consumables and Accessories, Revenue (USD Million) 2016 - 2026
  • 9.4.Filtration Systems
    • 9.4.1.Global Antibody Production Market for Filtration Systems, Revenue (USD Million) 2016 - 2026
• Chapter 10.Upstream Segmentation Analysis
  • 10.1.Global Antibody Production Market Overview: by Upstream Segment
    • 10.1.1.Global Antibody Production Market Revenue Share, by Upstream Segment, 2019 & 2026
  • 10.2.Global Antibody Production Market Analysis/Overview – By Upstream Segment
    • 10.2.1.Consumables – Overview/Analysis
    • 10.2.2.Bioreactors – Overview/Analysis
  • 10.3.Consumables
    • 10.3.1.Global Antibody Production Market for Consumables, Revenue (USD Million) 2016 - 2026
  • 10.4.Bioreactors
    • 10.4.1.Global Antibody Production Market for Bioreactors, Revenue (USD Million) 2016 - 2026
• Chapter 11.Consumables Segmentation Analysis
  • 11.1.Global Antibody Production Market Overview: by Consumables
    • 11.1.1.Global Antibody Production Market Revenue Share, by Consumables, 2019 & 2026
  • 11.2.Global Antibody Production Market Analysis/Overview – By Consumables
    • 11.2.1.Buffers & Reagents – Overview/Analysis
    • 11.2.2.Media – Overview/Analysis
  • 11.3.Buffers & Reagents
    • 11.3.1.Global Antibody Production Market for Buffers & Reagents, Revenue (USD Million) 2016 - 2026
  • 11.4.Media
    • 11.4.1.Global Antibody Production Market for Media, Revenue (USD Million) 2016 - 2026
• Chapter 12.Bioreactors Segmentation Analysis
  • 12.1.Global Antibody Production Market Overview: by Bioreactors
    • 12.1.1.Global Antibody Production Market Revenue Share, by Bioreactors, 2019 & 2026
  • 12.2.Global Antibody Production Market Analysis/Overview – By Bioreactors
    • 12.2.1.Single-Use Bioreactors – Overview/Analysis
    • 12.2.2.Large-Scale Bioreactors – Overview/Analysis
  • 12.3.Single-Use Bioreactors
    • 12.3.1.Global Antibody Production Market for Single-Use Bioreactors, Revenue (USD Million) 2016 - 2026
  • 12.4.Large-Scale Bioreactors
    • 12.4.1.Global Antibody Production Market for Large-Scale Bioreactors, Revenue (USD Million) 2016 - 2026
• Chapter 13.Antibody Production Market – Regional Analysis
  • 13.1.Global Antibody Production Market: Regional Overview
    • 13.1.1.Global Antibody Production Market Revenue Share, by Region, 2019 & 2026
    • 13.1.2.Global Antibody Production Market Revenue, by Region, 2016 – 2026 (USD Million)
  • 13.2.North America
    • 13.2.1.North America Antibody Production Market Revenue, 2016 - 2026 (USD Million)
    • 13.2.2.North America Antibody Production Market Revenue, by Country, 2016 – 2026 (USD Million)
    • 13.2.3.North America Antibody Production Market Revenue, by End User, 2016 – 2026
    • 13.2.4.North America Antibody Production Market Revenue, by Process, 2016 – 2026
    • 13.2.5.North America Antibody Production Market Revenue, by Filtration Segment, 2016 – 2026
    • 13.2.6.North America Antibody Production Market Revenue, by Upstream Segment, 2016 – 2026
    • 13.2.7.North America Antibody Production Market Revenue, by Consumables, 2016 – 2026
    • 13.2.8.North America Antibody Production Market Revenue, by Bioreactors, 2016 – 2026
    • 13.2.9. U.S.
    • 13.2.10.Canada
  • 13.3.Europe
    • 13.3.1.Europe Antibody Production Market Revenue, 2016 - 2026 (USD Million)
    • 13.3.2.Europe Antibody Production Market Revenue, by Country, 2016 – 2026 (USD Million)
    • 13.3.3.Europe Antibody Production Market Revenue, by End User, 2016 – 2026
    • 13.3.4.Europe Antibody Production Market Revenue, by Process, 2016 – 2026
    • 13.3.5.Europe Antibody Production Market Revenue, by Filtration Segment, 2016 – 2026
    • 13.3.6.Europe Antibody Production Market Revenue, by Upstream Segment, 2016 – 2026
    • 13.3.7.Europe Antibody Production Market Revenue, by Consumables, 2016 – 2026
    • 13.3.8.Europe Antibody Production Market Revenue, by Bioreactors, 2016 – 2026
    • 13.3.9.Germany
    • 13.3.10.France
    • 13.3.11. U.K.
    • 13.3.12.Italy
    • 13.3.13.Spain
    • 13.3.14.Rest of Europe
  • 13.4.Asia Pacific
    • 13.4.1.Asia Pacific Antibody Production Market Revenue, 2016 - 2026 (USD Million)
    • 13.4.2.Asia Pacific Antibody Production Market Revenue, by Country, 2016 – 2026 (USD Million)
    • 13.4.3.Asia Pacific Antibody Production Market Revenue, by End User, 2016 – 2026
    • 13.4.4.Asia Pacific Antibody Production Market Revenue, by Process, 2016 – 2026
    • 13.4.5.Asia Pacific Antibody Production Market Revenue, by Filtration Segment, 2016 – 2026
    • 13.4.6.Asia Pacific Antibody Production Market Revenue, by Upstream Segment, 2016 – 2026
    • 13.4.7.Asia Pacific Antibody Production Market Revenue, by Consumables, 2016 – 2026
    • 13.4.8.Asia Pacific Antibody Production Market Revenue, by Bioreactors, 2016 – 2026
    • 13.4.9.China
    • 13.4.10.Japan
    • 13.4.11.India
    • 13.4.12.South Korea
    • 13.4.13.South-East Asia
    • 13.4.14.Rest of Asia Pacific
  • 13.5.Latin America
    • 13.5.1.Latin America Antibody Production Market Revenue, 2016 - 2026 (USD Million)
    • 13.5.2.Latin America Antibody Production Market Revenue, by Country, 2016 – 2026 (USD Million)
    • 13.5.3.Latin America Antibody Production Market Revenue, by End User, 2016 – 2026
    • 13.5.4.Latin America Antibody Production Market Revenue, by Process, 2016 – 2026
    • 13.5.5.Latin America Antibody Production Market Revenue, by Filtration Segment, 2016 – 2026
    • 13.5.6.Latin America Antibody Production Market Revenue, by Upstream Segment, 2016 – 2026
    • 13.5.7.Latin America Antibody Production Market Revenue, by Consumables, 2016 – 2026
    • 13.5.8.Latin America Antibody Production Market Revenue, by Bioreactors, 2016 – 2026
    • 13.5.9.Brazil
    • 13.5.10.Mexico
    • 13.5.11.Rest of Latin America
  • 13.6.The Middle-East and Africa
    • 13.6.1.The Middle-East and Africa Antibody Production Market Revenue, 2016 - 2026 (USD Million)
    • 13.6.2.The Middle-East and Africa Antibody Production Market Revenue, by Country, 2016 – 2026 (USD Million)
    • 13.6.3.The Middle-East and Africa Antibody Production Market Revenue, by End User, 2016 – 2026
    • 13.6.4.The Middle-East and Africa Antibody Production Market Revenue, by Process, 2016 – 2026
    • 13.6.5.The Middle-East and Africa Antibody Production Market Revenue, by Filtration Segment, 2016 – 2026
    • 13.6.6.The Middle-East and Africa Antibody Production Market Revenue, by Upstream Segment, 2016 – 2026
    • 13.6.7.The Middle-East and Africa Antibody Production Market Revenue, by Consumables, 2016 – 2026
    • 13.6.8.The Middle-East and Africa Antibody Production Market Revenue, by Bioreactors, 2016 – 2026
    • 13.6.9.GCC Countries
    • 13.6.10.South Africa
    • 13.6.11.Rest of Middle-East Africa
• Chapter 14.Company Profiles
  • 14.1.Sigma-Aldrich Corporatio
    • 14.1.1.Company Overview
    • 14.1.2.Financial Overview
    • 14.1.3.Product Portfulio
    • 14.1.4.Business Strategy
    • 14.1.5.Recent Developments
  • 14.2.GE Healthcar
  • 14.3.Thermo Fisher Scientific, Inc.
  • 14.4.INTEGRA Biosciences AG
  • 14.5.Cellab GmbH
  • 14.6.Eppendorf AG.
  • 14.7.Sartorius AG
  • 14.8.Pall Corporation
  • 14.9.Merck KGaA
  • 14.1.FiberCell Systems Inc.

Methodology